Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 17 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.72 Insider Own18.91% Shs Outstand70.69M Perf Week5.00%
Market Cap223.46M Forward P/E- EPS next Y-0.29 Insider Trans0.14% Shs Float57.53M Perf Month-1.87%
Income-50.68M PEG- EPS next Q-0.23 Inst Own60.20% Short Float4.90% Perf Quarter-17.97%
Sales0.47M P/S475.45 EPS this Y-16.82% Inst Trans2.24% Short Ratio14.03 Perf Half Y-6.25%
Book/sh1.11 P/B2.85 EPS next Y66.70% ROA-36.86% Short Interest2.82M Perf Year-9.22%
Cash/sh1.27 P/C2.48 EPS next 5Y- ROE-50.87% 52W Range2.57 - 4.14 Perf YTD-2.17%
Dividend Est.- P/FCF- EPS past 5Y18.87% ROI-41.30% 52W High-23.89% Beta0.60
Dividend TTM- Quick Ratio10.47 Sales past 5Y275.67% Gross Margin-181.84% 52W Low22.57% ATR (14)0.16
Dividend Ex-Date- Current Ratio10.47 EPS Y/Y TTM1.71% Oper. Margin-13052.11% RSI (14)50.76 Volatility5.74% 5.21%
Employees40 Debt/Eq0.58 Sales Y/Y TTM283.30% Profit Margin-10701.82% Recom1.22 Target Price7.93
Option/ShortYes / Yes LT Debt/Eq0.57 EPS Q/Q12.72% Payout- Rel Volume0.44 Prev Close3.28
Sales Surprise184.07% EPS Surprise23.94% Sales Q/Q123.70% EarningsMay 14 BMO Avg Volume201.04K Price3.15
SMA200.95% SMA502.46% SMA200-7.31% Trades Volume88,874 Change-3.82%
Date Action Analyst Rating Change Price Target Change
Apr-30-24Initiated B. Riley Securities Buy $9
Apr-29-24Initiated H.C. Wainwright Buy $9
Apr-05-24Initiated Wedbush Outperform $8
Dec-21-23Initiated BTIG Research Buy $11
Oct-13-23Initiated Oppenheimer Outperform $8
Apr-20-21Downgrade Cantor Fitzgerald Buy → Neutral $4
Mar-03-21Downgrade RBC Capital Mkts Outperform → Sector Perform $5
Dec-02-20Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-02-20Downgrade Citigroup Buy → Neutral $10 → $4
Sep-04-19Initiated RBC Capital Mkts Outperform $12
May-14-24 01:54PM
May-13-24 07:00AM
Apr-30-24 07:23AM
07:18AM Loading…
Apr-29-24 07:18AM
Apr-26-24 10:00AM
Apr-04-24 08:00AM
Mar-17-24 05:19PM
Mar-08-24 08:00AM
Feb-28-24 08:00AM
Feb-06-24 08:00AM
Dec-01-23 07:30AM
Nov-09-23 12:00PM
07:15PM Loading…
Nov-05-23 07:15PM
Nov-03-23 08:00AM
Oct-19-23 10:44AM
Oct-18-23 08:00AM
Oct-10-23 08:00AM
Sep-29-23 03:16PM
Sep-26-23 07:30AM
Sep-20-23 07:30AM
Aug-30-23 08:00AM
Aug-15-23 09:38PM
Aug-04-23 09:15AM
Aug-01-23 08:00AM
Jul-31-23 09:29PM
Jul-02-23 10:00AM
08:00AM Loading…
Jun-28-23 08:00AM
Jun-26-23 08:00AM
May-22-23 06:43AM
May-05-23 08:45AM
May-01-23 06:00AM
Apr-27-23 02:30PM
Apr-12-23 12:00PM
Apr-11-23 06:51AM
Apr-10-23 08:00AM
Mar-15-23 06:21AM
Mar-13-23 08:00AM
Mar-09-23 08:00AM
Mar-08-23 08:00AM
Feb-28-23 08:00AM
Feb-08-23 08:00AM
Jan-22-23 07:37AM
Jan-05-23 08:00AM
Dec-02-22 10:00AM
Nov-17-22 07:23AM
Nov-08-22 08:00AM
Oct-18-22 08:57AM
Sep-27-22 08:00AM
Sep-26-22 09:21AM
Sep-07-22 08:00AM
Aug-14-22 10:40AM
Aug-09-22 08:00AM
Jun-10-22 07:41AM
Jun-06-22 08:00AM
May-11-22 06:55AM
May-10-22 08:00AM
Apr-26-22 07:17AM
Apr-08-22 08:00AM
Mar-15-22 08:00AM
Mar-07-22 01:06PM
Mar-04-22 08:00AM
Feb-28-22 01:51PM
Feb-08-22 08:00AM
Jan-04-22 08:01AM
Jan-03-22 07:25AM
Nov-10-21 08:30AM
Nov-05-21 12:03PM
Oct-07-21 08:30AM
Sep-07-21 08:00AM
Sep-06-21 12:58PM
Aug-16-21 08:00AM
Jul-08-21 04:30PM
Jul-07-21 08:00AM
Jul-06-21 07:01AM
Jun-04-21 08:00AM
May-26-21 08:00AM
May-24-21 07:52AM
May-21-21 08:46AM
May-20-21 09:29AM
May-13-21 04:05PM
May-12-21 08:00AM
May-07-21 08:42AM
Apr-30-21 11:37AM
Apr-20-21 08:00AM
Apr-19-21 09:16AM
Mar-30-21 08:00AM
Mar-20-21 04:51AM
Mar-16-21 08:39AM
Mar-15-21 08:00AM
Mar-10-21 03:44AM
Mar-03-21 07:46AM
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVIN JEREMY MCEOMar 18 '24Buy2.7618,24850,3643,616,715Mar 20 05:22 PM